PCI围术期心肌损伤与梗死预后相关性的共识文件
该共识由ESC心脏细胞生物学工作组与EAPCI制定,针对接受PCI的慢性冠脉综合征(CCS)患者,推荐尽可能测量基线及术后心脏肌钙蛋白(cTn)。共识确认术后cTn>5倍99百分位URL定义的4a型心肌梗死具有预后意义,并提出在无血流受限并发症或缺血证据时,同一阈值可用于定义预后相关的「重大」围术期心肌损伤。
要点
- 推荐所有接受PCI的CCS患者尽可能测量术前和术后cTn。
- 术后cTn>5倍99百分位URL定义的4a型心梗是1年全因死亡的独立预测因子。
- 无血流受限并发症或缺血证据时,同一阈值可定义「重大」围术期心肌损伤。
核心结论
- 术后cTn>5倍99百分位URL定义的4a型心肌梗死和重大围术期心肌损伤均为PCI后1年全因死亡的强独立预测因子。
- 二者可用作质量指标和临床试验的替代终点。
研究设计与样本
- ESC心脏细胞生物学工作组与EAPCI的共识文件,基于专家共识意见制定。
主要发现
- 接受PCI的CCS患者中相当数量发生围术期心肌损伤或梗死,与主要不良心脏事件(MACE)风险增加相关。
- 术后cTn>5倍99百分位URL定义的4a型心肌梗死具有预后相关性。
- 无围术期造影血流受限并发症或心电图/影像新发心肌缺血证据时,同一阈值可用于定义预后相关的「重大」围术期心肌损伤。
关键数值与推荐
- 推荐所有接受PCI的CCS患者尽可能测量基线(术前)和术后cTn值。
- 术后cTn>5倍99百分位URL用于定义4a型心肌梗死。
- 无血流受限并发症或缺血证据时,术后cTn>5倍99百分位URL用于定义「重大」围术期心肌损伤。
临床怎么用
- 对接受PCI的CCS患者应尽可能测量术前和术后cTn以识别围术期心肌损伤或梗死。
- 术后cTn>5倍99百分位URL提示预后相关事件,可作为质量指标。
局限性
- 术后cTn升高的截断阈值基于专家共识意见,因缺乏科学数据。
- 其预后相关性尚不完全明确。
- 需进一步研究评估降低重大围术期心肌损伤、4a型心肌梗死及MACE风险的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A substantial number of chronic coronary syndrome (CCS) patients undergoing percutaneous coronary intervention (PCI) experience periprocedural myocardial injury or infarction. Accurate diagnosis of these PCI-related complications is required to guide further management given that their occurrence may be associated with increased risk of major adverse cardiac events (MACE). Due to lack of scientific data, the cut-off thresholds of post-PCI cardiac troponin (cTn) elevation used for defining periprocedural myocardial injury and infarction, have been selected based on expert consensus opinions, and their prognostic relevance remains unclear. In this Consensus Document from the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI), we recommend, whenever possible, the measurement of baseline (pre-PCI) cTn and post-PCI cTn values in all CCS patients undergoing PCI. We confirm the prognostic relevance of the post-PCI cTn elevation >5× 99th percentile URL threshold used to define type 4a myocardial infarction (MI). In the absence of periprocedural angiographic flow-limiting complications or electrocardiogram (ECG) and imaging evidence of new myocardial ischaemia, we propose the same post-PCI cTn cut-off threshold (>5× 99th percentile URL) be used to define prognostically relevant 'major' periprocedural myocardial injury. As both type 4a MI and major periprocedural myocardial injury are strong independent predictors of all-cause mortality at 1 year post-PCI, they may be used as quality metrics and surrogate endpoints for clinical trials. Further research is needed to evaluate treatment strategies for reducing the risk of major periprocedural myocardial injury, type 4a MI, and MACE in CCS patients undergoing PCI.
引用
- Bulluck H, Paradies V, Barbato E, et al. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2021. PMID: 34059914. doi:10.1093/eurheartj/ehab271
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。